Profusa (NASDAQ:PFSA) Posts Earnings Results

Profusa (NASDAQ:PFSA) posted its quarterly earnings results on Friday. The company reported ($6.23) earnings per share (EPS) for the quarter, FiscalAI reports.

Profusa Trading Down 2.6%

PFSA stock traded down $0.01 during mid-day trading on Friday, hitting $0.45. The stock had a trading volume of 406,978 shares, compared to its average volume of 2,762,980. Profusa has a 1-year low of $0.40 and a 1-year high of $1,539.75. The company has a fifty day moving average of $1.43 and a 200 day moving average of $62.72. The stock has a market capitalization of $271,488.00, a price-to-earnings ratio of -0.00 and a beta of 0.62.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Weiss Ratings upgraded shares of Profusa from a “sell (e)” rating to a “sell (e+)” rating in a research report on Thursday, August 27th. Wall Street Zen upgraded shares of Profusa to a “sell” rating in a report on Saturday, August 22nd. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, Profusa currently has a consensus rating of “Sell”.

About Profusa

Profusa, Inc. is a biotechnology and medical-device company focused on developing implantable biosensors designed to continuously monitor biochemical conditions inside the body. Its technology is intended to provide real-time health data without requiring repeated blood draws or external sampling. The company’s biosensors are designed to be placed under the skin and remain in the body while communicating measurements to an external reader or connected device. Profusa has developed platforms intended to monitor markers such as tissue oxygen levels, with potential applications in areas including peripheral artery disease, wound care, chronic disease management and clinical research.